Analysis in progress: 97,639 of 97,778 records assessed (99.9%). Totals and rankings will change until it finishes. Progress details
Search Assembly records
Every imported question, contribution and motion, with its classification. Unflagged, uncertain and not-yet-analysed records are all included so the analysis can be checked independently.
To ask the Minister for Communities whether businesses affected by racist attacks in August 2024 will be encouraged to avail of the recent £200,000 funding announcement on the same terms as the other businesses.
To ask the Minister for Communities to detail the measures that are intended to be put in place to ensure that the Movilla Stones are protected from further deterioration upon their return to Movilla Abbey.
To ask the Minister for Communities for an update on when the Movilla Stones, which were removed from Movilla Abbey and are currently in the possession of Historic Environment Division, will be returned.
To ask the Minister for Communities to detail the number of individuals in temporary or emergency housing placements who are subject to bail conditions in the last 12 months, broken down by local council area.
To ask the Minister for Communities to detail any steps his Department is taking to improve access to social housing for older people in (i) rural areas; and (ii) coastal areas.
Extension of Committee Stage: Sign Language Bill (NIA Bill 10/22-27) That, in accordance with Standing Order 33(4), the period referred to in Standing Order 33(2) be extended to 13 February 2026, in relation to the Committee Stage of the Sign Language Bill.
Motion Amendment · Private Members' Motion · to “Reclassification of Ketamine”
Reclassification of Ketamine - Amendment 1 Leave out all after ‘family;’and insert: 'notes the UK Government’s decision to commission advice on whether ketamine should become a Class A drug; calls on the Minister of Justice to work with the Home Office to put in place arrangements to allow affected families and…
To ask the Minister of Health to outline how any lessons learned from the first year of implementing the Autism Strategy 2023-2028 will inform the next phase.
To ask the Minister of Health to outline what steps are being taken to ensure that givinostat, used to treat Duchenne muscular dystrophy, will be available through an Early Access Programme.